Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)

Tonghua Dongbao Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	477.4	1,104	788.06	865.04	593.38	368.01
Short-Term Investments	-	-	-	-	-	202.74
Trading Asset Securities	35	55.52	58.46	37	150.37	-
Cash & Short-Term Investments	512.4	1,160	846.52	902.04	743.74	570.75
Cash Growth	-9.97%	37.00%	-6.15%	21.28%	30.31%	-15.94%
Accounts Receivable	606.49	869.74	455.99	650.94	571.27	642.44
Other Receivables	8.31	8.79	20.56	7.63	18.05	54.64
Receivables	614.8	878.53	476.55	658.57	589.32	697.09
Inventory	779.82	705.35	653.9	537.92	537.58	628.76
Prepaid Expenses	0.13	-	0.02	0.03	0.57	-
Other Current Assets	121.97	72.76	79.43	63.9	51.2	30.04
Total Current Assets	2,029	2,816	2,056	2,162	1,922	1,927
Property, Plant & Equipment	2,662	2,671	2,678	2,392	2,288	2,111
Long-Term Investments	556.01	435.01	362.49	457.91	461.79	355.77
Other Intangible Assets	631.89	670.02	487.01	389.07	256.32	256.33
Long-Term Deferred Tax Assets	106.05	38.55	46.19	42.41	37.75	37.79
Long-Term Deferred Charges	805.28	690.91	607.25	447.29	357.83	219.42
Other Long-Term Assets	253.62	449.84	513.13	628.85	479.58	442.95
Total Assets	7,044	7,771	6,750	6,520	5,803	5,350
Accounts Payable	132.7	115.9	80.86	75	68.17	69.15
Accrued Expenses	3.91	30.93	11.03	31.74	15.99	19.21
Short-Term Debt	251.5	150	-	-	-	125
Current Income Taxes Payable	0.19	52.46	-	80.45	37.48	34.72
Current Unearned Revenue	2.22	10.48	21.08	7.89	8.17	-
Other Current Liabilities	16.26	160.39	49.08	73.47	78.37	56.77
Total Current Liabilities	406.78	520.16	162.05	268.55	208.18	304.85
Long-Term Debt	107.5	-	2.65	2.65	2.65	2.65
Long-Term Unearned Revenue	26.76	27.51	28.53	28.67	32.91	33.37
Long-Term Deferred Tax Liabilities	7.22	7.41	7.51	-	0.06	0.23
Total Liabilities	548.27	555.08	200.74	299.87	243.8	341.1
Common Stock	1,982	1,994	1,994	2,034	2,034	2,034
Additional Paid-In Capital	505.16	622.56	641.9	1,006	1,034	934.61
Retained Earnings	3,999	4,725	4,053	3,567	2,679	2,157
Treasury Stock	-	-134.83	-150.37	-398.13	-200.49	-133.46
Comprensive Income & Other	5.28	5.28	6.39	6.94	7.48	8.25
Total Common Equity	6,491	7,211	6,544	6,215	5,554	5,000
Minority Interest	5.05	5.09	5.31	5.35	5.47	8.42
Shareholders' Equity	6,496	7,216	6,550	6,220	5,559	5,009
Total Liabilities & Equity	7,044	7,771	6,750	6,520	5,803	5,350
Total Debt	359	150	2.65	2.65	2.65	127.65
Net Cash (Debt)	153.4	1,010	843.87	899.39	741.09	443.1
Net Cash Growth	-69.27%	19.65%	-6.17%	21.36%	67.25%	96.91%
Net Cash Per Share	0.08	0.51	0.42	0.44	0.37	0.22
Filing Date Shares Outstanding	1,982	1,916	1,984	2,018	2,018	2,018
Total Common Shares Outstanding	1,982	1,916	1,984	2,018	2,018	2,023
Working Capital	1,622	2,296	1,894	1,894	1,714	1,622
Book Value Per Share	3.28	3.76	3.30	3.08	2.75	2.47
Tangible Book Value	5,859	6,541	6,057	5,826	5,298	4,744
Tangible Book Value Per Share	2.96	3.41	3.05	2.89	2.63	2.34
Buildings	1,417	1,437	1,452	1,305	1,198	1,160
Machinery	1,545	1,532	1,591	1,301	1,431	1,314
Construction In Progress	1,367	1,319	1,158	1,203	1,210	1,087

Source: S&P Capital IQ. Standard template. Financial Sources.